Key result
Cathepsin B inhibition prolongs cardiac allograft survival in mice by curbing macrophage lipid peroxidation.
Why the study?
The contribution of lipid peroxidation to macrophage pro-inflammatory reprogramming in acute cardiac allograft rejection and its underlying regulation remain unclear. Whether cathepsin B promotes macrophage pro-inflammatory reprogramming through lipid peroxidation to exacerbate acute rejection remains to be elucidated.
Does macrophage-targeted Ctsb gene silencing or CA-074Me administration improve graft survival and reduce macrophage lipid peroxidation and pro-inflammatory reprogramming in a mouse model of acute cardiac allograft rejection?
Does macrophage-targeted Ctsb gene silencing or CA-074Me administration improve graft survival and reduce macrophage lipid peroxidation and pro-inflammatory reprogramming in a mouse model of acute cardiac allograft rejection?
Targeting cathepsin B (CTSB) via gene silencing or CA-074Me alleviates graft inflammatory injury and prolongs graft survival in a mouse model of acute cardiac allograft rejection by inhibiting GPX4 degradation and macrophage lipid peroxidation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for CTSB inhibition in murine cardiac rejection; leaves open translation to human allograft survival.
Acute rejection (AR) is a major cause of cardiac graft dysfunction. Current T cell-targeted strategies provide limited control over macrophage-mediated innate immune responses. Macrophage pro-inflammatory reprogramming plays an important role in the progression of AR, but the contribution of lipid peroxidation to this process and its underlying regulation remain unclear. Cathepsin B (CTSB), a lysosomal cysteine protease implicated in ferroptosis and immune regulation, may provide a mechanistic link between lipid peroxidation and macrophage inflammatory responses. However, whether CTSB promotes macrophage pro-inflammatory reprogramming through lipid peroxidation and thereby exacerbates AR remains to be elucidated. In this study, a mouse heterotopic heart transplantation model and a macrophage-T cell co-culture system were constructed. Through the adeno-associated virus serotype 9-mediated macrophage-targeted Ctsb gene silencing and CA-074Me pharmacological intervention, the in vitro and in vivo functions of CTSB were systematically verified. Using lipid peroxidation assays and protein interaction analyses, we further investigated the mechanisms underlying macrophage lipid peroxidation and pro-inflammatory reprogramming. In the acute rejection model of heart transplantation, CTSB and its mature form in graft-infiltrating macrophages were significantly upregulated. Macrophage-targeted knockdown of Ctsb or administration of CA-074Me significantly prolonged graft survival, reduced tissue damage and inflammatory infiltration, and effectively inhibited macrophage lipid peroxidation, pro-inflammatory reprogramming and Th1 immune response. Mechanism studies have shown that the rejection microenvironment after transplantation can induce macrophage lysosomal acidification, thereby promoting CTSB maturation. Our findings suggest that mature CTSB contributes to lysosomal GPX4 degradation involving CMA-associated machinery, thereby promoting lipid peroxidation and intracellular ROS accumulation in macrophages and enhancing their pro-inflammatory reprogramming during acute rejection. The lysosomal acidification-CTSB maturation-GPX4 axis represents a key mechanism driving macrophage pro-inflammatory reprogramming through lipid peroxidation during acute cardiac allograft rejection. Targeting CTSB effectively alleviated graft inflammatory injury and prolonged graft survival, suggesting that CTSB may serve as a promising therapeutic target for the treatment of acute cardiac allograft rejection. The protective effects of CA-074Me in this mouse model support further preclinical evaluation of CTSB-targeted therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2026) studied Acute cardiac allograft rejection. AAV9-mediated macrophage-targeted Ctsb gene silencing or CA-074Me pharmacological intervention was evaluated on Graft survival, tissue damage, inflammatory infiltration, and macrophage lipid peroxidation and pro-inflammatory reprogramming. AAV9-mediated Ctsb knockdown or CA-074Me administration inhibited macrophage lipid peroxidation and pro-inflammatory reprogramming, prolonging cardiac allograft survival in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: